Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Liraglutide for Sale > Laboratory Research Retatrutide Peptide, Lyophilized Powder 10mg In Single Vial
Laboratory Research Retatrutide Peptide, Lyophilized Powder 10mg In Single Vial buy - large image1
Laboratory Research Retatrutide Peptide, Lyophilized Powder 10mg In Single Vial buy - image1
Laboratory Research Retatrutide Peptide, Lyophilized Powder 10mg In Single Vial buy - image2
Laboratory Research Retatrutide Peptide, Lyophilized Powder 10mg In Single Vial buy - image3
Laboratory Research Retatrutide Peptide, Lyophilized Powder 10mg In Single Vial buy - image4
Laboratory Research Retatrutide Peptide, Lyophilized Powder 10mg In Single Vial buy - image5
Laboratory Research Retatrutide Peptide, Lyophilized Powder 10mg In Single Vial buy - image6

Laboratory Research Retatrutide Peptide, Lyophilized Powder 10mg In Single Vial

24 Inquiries

Unit Price:

$53/UNIT EXW

Get Latest Price
CAS No.:

204656-20-2

Grade:

Research Grade

Content:

99%

Port:

qingdao

Brand:

Peptide

Packaging:

5mg;10mg;15mg;20mg;30mg;40mg;50mg;100mg;500mg

Price valid (until):

2026-11-19

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Cosmetics

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Company Profile

    Our enterprise focuses on developing and supplying synthetic peptide raw materials for life science laboratory research. We have built standardized production workflows and assembled an experienced technical and sales team. We can tailor raw material solutions according to each lab’s experimental design, serving researchers across multiple regions worldwide.

    We uphold integrity and consistent product performance as our core principles. We keep track of evolving needs within the research community and adjust our inventory and supply plans accordingly. From initial consultation and order confirmation through production scheduling and dispatch, we aim to deliver streamlined service for every submission.

    Product Details

    This product line comprises research-grade synthetic peptide lyophilized powder, manufactured via chemical synthesis followed by freeze-drying processing. The lyophilization process lowers moisture levels, slows molecular degradation, and helps preserve material stability over storage.

    Each batch features fine, homogeneous powder that dissolves readily in compatible solvents, with low impurity profiles and consistent performance across production runs. It serves as a reliable material for biochemical assays, in vitro experiments and academic research projects.

    We support small trial batches as well as large-volume orders. Unit pricing becomes more competitive for larger quantities. Custom packaging arrangements can also be discussed to accommodate different laboratory operational preferences.

    Product Consistency

    We maintain careful oversight throughout the whole production workflow. Starting materials are sourced from qualified suppliers and reviewed before entering production.

    Synthesis and purification follow established operating procedures. Finished materials undergo multiple analytical assessments to confirm purity, moisture content and impurity profiles.

    Materials are cleared for dispatch once evaluation criteria are met. Batch records are retained, and relevant supporting documentation can be shared to support your research records upon request.

    Packaging and Logistics

    Our inner packaging uses professional light-blocking sealed vials. Outer packaging includes protective cushioning to reduce mechanical shock and temperature variation risks during transit.

    We work with trusted international logistics partners. Shipment will be arranged within 1–2 business days after payment confirmation, and a tracking number will be provided for shipment monitoring.

    Support Services

    Our sales and technical team provides dedicated support for laboratory buyers and responds to inquiries within 24 business hours.

    You may reach out for guidance on product selection, storage recommendations, order updates or packaging preferences. Custom labeling and repackaging options can be explored where feasible.

    After shipment, we continue tracking delivery progress. Please contact us promptly if any issues arise upon receipt, and we will work toward a suitable resolution.

    Storage Conditions

    Store in a cool, dry, dark, low-temperature environment. Avoid repeated freeze-thaw cycles. We recommend aliquoting materials based on experimental usage to help maintain sample integrity.

    Important Disclaimer

    This product is intended exclusively for in vitro laboratory research. It may NOT be used for human, clinical, diagnostic, medical, cosmetic, food or feed applications. The purchaser shall bear responsibility to ensure the product is used solely within permitted laboratory research scope.

    Shop VIP High Grade Synthetic Lyophilized Peptide for Biochemical Lab Research-Detailed Image 1 Shop VIP High Grade Synthetic Lyophilized Peptide for Biochemical Lab Research-Detailed Image 2 Shop VIP High Grade Synthetic Lyophilized Peptide for Biochemical Lab Research-Detailed Image 3 Shop VIP High Grade Synthetic Lyophilized Peptide for Biochemical Lab Research-Detailed Image 4

    Items Specifications
    Product type Synthetic peptide
    Grade Research grade
    Purity ≥99%
    Appearance White / off‑white lyophilized powder
    Package form Sealed glass vials
    Available experimental sizes 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 100 mg, 500 mg
    Minimum order 1 kit (10 vials)
    ECHEMI Editorial Reference
    Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus.
    Liraglutide is characterized as a white to almost white powder. It is freely soluble in aqueous base solutions (> 270 mg/mL), but its water solubility decreases below pH 7 and reaches its lowest level at pH 4-5 (approximately 0.05 mg/mL). Solubility increases marginally at pH 2.5 where it is very slightly soluble (≤ 0.8 mg/mL). Liraglutide is soluble in methanol (68 mg/mL) and very slightly soluble in ethanol (1.1 mg/mL). The isoelectric point of liraglutide is approximately 4.9. The pH of a 1 mg/mL aqueous solution of drug substance is approximately 9.3.
    ChEBI: Liraglutide, a lipopeptide and polypeptide, is an analogue of human GLP-1 in which the lysine residue at position 27 is replaced by arginine and a hexadecanoyl group attached to the remaining lysine via a glutamic acid spacer. It is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Liraglutide functions as a glucagon-like peptide-1 receptor agonist and serves as a neuroprotective agent.
    Liraglutide is GLP-1(1–37) modified at Ly: the -amino group is acylated with an (N-hexadecanoyl)glutam- -yl moiety that noncovalently but avidly binds tohuman serum albumin. (Also, Lys is conservatively replacedwith Arg.) These changes provide for a greatly extendedserum t12 of~10 to 15 hours after sc administration(0.6–1.8 mg), allowing for once-daily dosing.Liraglutide (Victoza, Novo Nordisk) is awaiting approvalby the FDA, EMEA, and the Koˉ roˉ -shoˉ (Japan).
    Liraglutide peptide is a single, non-glycosylated polypeptide chain containing 31 amino acids, having a molecular mass of 3751 Dalton and a Molecular formula of C172H265N43O51.

    Basic Info
    Product Name:

    Liraglutide

    Other Name:

    Liraglutide;Glycine, L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-;Liraglutida;Liraglutida [inn-spanish];Liraglutide [usan:inn];Liraglutidum;Liraglutidum [inn-latin];N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glp-1-(7-37)-peptide

    CAS No.:

    204656-20-2

    Molecular Formula:

    C172H265N43O51

    InChIKeys:

    YSDQQAXHVYUZIW-VTFFJMQZNA-N

    Molecular Weight:

    3751.202

    Exact Mass:

    3748.95000

    EC Number:

    810-818-7

    Color/Form:

    White to Off-White

    Categories:

    Polypeptide

    Characteristics
    PSA:

    1513.76000

    XLogP3:

    6.12960

    Melting Point:

    >182°C (dec.)

    Critical Temperature & Pressure:

    Refrigerator

    Research
    Class:

    GLP-1 receptor agonist (acylated GLP-1 analog, 31-amino-acid peptide)

    Status:

    FDA-approved (Victoza 2010, Saxenda 2014 for obesity)

    Mechanism:

    A 31-amino-acid GLP-1 analog with a C16 fatty-acid chain (palmitoyl) attached to Lys26 via a gamma-glutamic acid spacer. This fatty-acid modification enables reversible binding to serum albumin, extending the half-life to ~13 hours. Activates GLP-1R to enhance glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite.

    EC50 (GLP1R Ec50):

    ~10 nM

    Source:

    DrugBank: DB06655; Knudsen LB, et al. J Med Chem. 2000;43(9):1664-1669.DOI

    Clinical Development:

    NCT00781922; NCT01272219

    FDA:

    Victoza, Saxenda (approved 2010-01-25)

    References
    ChEMBL:

    CHEMBL1213363

    DrugBank:

    DB06655

    KEGG DRUG:

    D09199

    PubChem:

    PubChem

    Disclaimer:

    Liraglutide is FDA-approved as a prescription medicine (Victoza for T2DM, Saxenda for obesity). This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

    Hazard Identification

    Classification of the substance or mixture

    Carcinogenicity, Category 2

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H351 Suspected of causing cancer

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Cosmetics

    Location:

    Room 204, Unit 1, Building 3, Liming 1st District, Choujiang Subdistrict, Wenwu City, Jinhua City, China (Zhejiang) Pilot Free Trade Zone

    Year of Establishment:

    2026

  • Inquiry History
    24 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    Liraglutide

    1.00 KG Oct 8, 2024
    United Kingdom

    Liraglutide

    20 MG Jul 8, 2026
    United States

    Mic (Lipo C with B12), VIP, Ss31, glutathione and, Reta

    50 MG Mar 4, 2026
    India

    liraglutide

    1 KG Feb 25, 2026
    United States

    liraglutide

    1  Jan 21, 2026
    United States

    liraglutide

    1 MT Nov 22, 2025
    Reunion Island

    Liraglutide

    1 G Apr 14, 2025
    United States

    Liraglut

    1 MT Feb 9, 2025
    Israel

    Liraglutide

    1 G Aug 26, 2024
    India

    Liraglutide

    10 G Jun 26, 2024
    India

    Liraglutide

    100 G Mar 4, 2024
    United States

    Semaglutide Liraglutide powder

    10 G Feb 20, 2024
    South Korea

    Liraglutide

    1 G Sep 19, 2026
    United States

    MIC

    2 MT May 20, 2026
    Canada

    Liraglutide

    1 KG Dec 8, 2025
    Brazil

    Liraglutida

    1 G Sep 29, 2025
    United States

    Liraglutide

    1 KG Aug 13, 2025
    Sweden

    liraglutide

    1 KG Aug 4, 2025
    Pakistan

    liraglutide injection

    50 KG Jan 21, 2025
    India

    Liraglutide

    10 MG Jul 17, 2024
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.